ABBOTT PARK, Ill., Aug.

WASHINGTON, Oct. 25 /PRNewswire-FirstCall/ -- A s

ABBOTT PARK, Ill., Sept. 13 /PRNewswire-FirstCall/ -- Abbott announced today CE Mark approval and European launch of the company's next- generation embolic protection device, the Emboshield(R) PRO Embolic Protection System.

ABBOTT PARK, Ill., Aug. 30 /PRNewswire-FirstCall/ -- Abbott today announced completion of enrollment in a landmark study designed to increase clinical understanding of "vulnerable" plaque -- a lipid-rich coronary plaque that suddenly ruptures -- believed to be the cause of most heart attacks.

ABBOTT PARK, Ill., Aug. 14 /PRNewswire-FirstCall/